WMT

130

-1.57%↓

COST

1,011.08

-0.32%↓

PEP

155.5

-0.17%↓

TGT

128.95

-0.98%↓

KR

67.35

-2.5%↓

WMT

130

-1.57%↓

COST

1,011.08

-0.32%↓

PEP

155.5

-0.17%↓

TGT

128.95

-0.98%↓

KR

67.35

-2.5%↓

WMT

130

-1.57%↓

COST

1,011.08

-0.32%↓

PEP

155.5

-0.17%↓

TGT

128.95

-0.98%↓

KR

67.35

-2.5%↓

WMT

130

-1.57%↓

COST

1,011.08

-0.32%↓

PEP

155.5

-0.17%↓

TGT

128.95

-0.98%↓

KR

67.35

-2.5%↓

WMT

130

-1.57%↓

COST

1,011.08

-0.32%↓

PEP

155.5

-0.17%↓

TGT

128.95

-0.98%↓

KR

67.35

-2.5%↓

Search

USANA Health Sciences Inc

Gesloten

19.37 2

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

19.19

Max

19.41

Belangrijke statistieken

By Trading Economics

Inkomsten

5.1M

-1.6M

Verkoop

13M

226M

K/W

Sectorgemiddelde

35.586

29.378

Winstmarge

-0.705

Werknemers

1,570

EBITDA

16M

28M

Dividenden

By Dow Jones

Volgende Winsten

5 mei 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-1.1M

381M

Vorige openingsprijs

17.37

Vorige sluitingsprijs

19.37

Technische score

By Trading Central

Vertrouwen

Weak Bullish Evidence

USANA Health Sciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

26 apr 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Major Central Bank Meetings Due as Middle East Conflict Continues

26 apr 2026, 21:14 UTC

Belangrijke Nieuwsgebeurtenissen

Week Ahead for FX, Bonds: Major Central Bank -2-

24 apr 2026, 19:19 UTC

Acquisities, Fusies, Overnames

Intertek Group Rejects EQT's Revised Offer

26 apr 2026, 23:48 UTC

Marktinformatie

Nikkei May Rise After U.S. Tech Gains -- Market Talk

26 apr 2026, 23:44 UTC

Winsten

Sinopharm 1Q Net CNY1.41B Vs. Net CNY1.46B >1099.HK

26 apr 2026, 23:44 UTC

Winsten

Sinopharm 1Q Rev CNY140.77B Vs. CNY141.66B >1099.HK

26 apr 2026, 23:36 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Gold Falls Amid Dollar's Strength -- Market Talk

26 apr 2026, 23:33 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Oil Rises Amid Ongoing Middle East Tensions -- Market Talk

26 apr 2026, 05:12 UTC

Winsten

Citic Securities: Results Also Aided by Higher Income from Brokerage, Income Banking Business >6030.HK

26 apr 2026, 05:12 UTC

Winsten

Citic Securities: Increase in Net Interest Income Supported Results >6030.HK

26 apr 2026, 05:12 UTC

Winsten

Citic Securities 1Q Rev CNY23.16B Vs. CNY16.43B >6030.HK

26 apr 2026, 05:12 UTC

Winsten

Citic Securities 1Q Net CNY10.22B Vs. Net CNY6.61B >6030.HK

24 apr 2026, 23:37 UTC

Acquisities, Fusies, Overnames

Scoring the Cook Era -- Barrons.com

24 apr 2026, 20:51 UTC

Acquisities, Fusies, Overnames

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 20:50 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Financial Services Roundup: Market Talk

24 apr 2026, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

24 apr 2026, 20:39 UTC

Acquisities, Fusies, Overnames

Organon Stock Surges 31% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 20:09 UTC

Winsten

Tesla Stock Rises After Upgrade But Heads for Weekly Loss. Why AI Is Key. -- Barrons.com

24 apr 2026, 19:48 UTC

Marktinformatie
Belangrijke Nieuwsgebeurtenissen

Oil Posts Weekly Gains on Continued Hormuz Closure -- Market Talk

24 apr 2026, 19:25 UTC

Acquisities, Fusies, Overnames

Organon Stock Surges 30% on Sweetened $13 Billion Takeover Offer From Sun Pharma -- Barrons.com

24 apr 2026, 19:25 UTC

Acquisities, Fusies, Overnames

QXO Continues to Tumble Following TopBuild Deal -- Barrons.com

24 apr 2026, 19:22 UTC

Winsten

Dell AI Infrastructure Deal Shows That Hyperscalers Aren't the Only Players. Plus, Adobe and 4 More Stocks. -- Barrons.com

24 apr 2026, 19:06 UTC

Winsten

Earnings Season Was Supposed to Drive the Stock Market. Why It Hasn't. -- Barrons.com

24 apr 2026, 19:05 UTC

Marktinformatie

U.S. Natural Gas Falls As Market Frets Over Storage -- Market Talk

24 apr 2026, 18:30 UTC

Acquisities, Fusies, Overnames

Intertek: EQT's GBP54/Shr Offer 'Fundamentally Undervalues Intertek and Its Future Prospects'

24 apr 2026, 18:28 UTC

Acquisities, Fusies, Overnames

Intertek Rejects Revised EQT Offer

24 apr 2026, 18:12 UTC

Marktinformatie

Precious Metals Rise, But Remain Negative for the Week -- Market Talk

24 apr 2026, 18:06 UTC

Marktinformatie

Oil Futures Extend Losses on Plans for U.S.-Iran Talks -- Market Talk

24 apr 2026, 17:42 UTC

Winsten

Even Nvidia Stock Is Getting an Intel Boost. It's on Pace for a Record High. -- Barrons.com

24 apr 2026, 17:28 UTC

Winsten

Palantir Stock Is Down 20% in 2026. Why This Analyst Says It's a Buy. -- Barrons.com

Peer Vergelijking

Prijswijziging

USANA Health Sciences Inc Prognose

Beoordelingsconsensus

By TipRanks

0 ratings

0

Buy

0

Hold

0

Sell

Technische score

By Trading Central

28.405 / 29.84Steun & Weerstand

Korte Termijn

Weak Bullish Evidence

Gemiddeld Termijn

Bullish Evidence

Lange Termijn

No Evidence

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat